Logo: to the web site of Uppsala University

uu.sePublications from Uppsala University
Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
Phosphodiesterase 10A levels are related to striatal function in schizophrenia: a combined positron emission tomography and functional magnetic resonance imaging study
Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Medicine, Department of Neuroscience, Ekselius: Psychiatry.ORCID iD: 0000-0003-2162-0949
Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Medicine, Department of Neuroscience, Ekselius: Psychiatry.
Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Pharmacy, Department of Medicinal Chemistry, Preclinical PET-MRI Platform. Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Pharmacy, Department of Medicinal Chemistry, Preparative Medicinal Chemistry. PET-Centre, Uppsala University Hospital.ORCID iD: 0000-0002-1525-5255
Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Medicine, Department of Surgical Sciences, Radiology. PET-Centre, Uppsala University Hospital.ORCID iD: 0000-0003-3671-127X
Show others and affiliations
2020 (English)In: European Archives of Psychiatry and Clinical Neuroscience, ISSN 0940-1334, E-ISSN 1433-8491, Vol. 270, no 4, p. 451-459Article in journal (Refereed) Published
Abstract [en]

Pharmacological inhibition of phosphodiesterase 10A (PDE10A) is being investigated as a treatment option in schizophrenia. PDE10A acts postsynaptically on striatal dopamine signaling by regulating neuronal excitability through its inhibition of cyclic adenosine monophosphate (cAMP), and we recently found it to be reduced in schizophrenia compared to controls. Here, this finding of reduced PDE10A in schizophrenia was followed up in the same sample to investigate the effect of reduced striatal PDE10A on the neural and behavioral function of striatal and downstream basal ganglia regions. A positron emission tomography (PET) scan with the PDE10A ligand [11C]Lu AE92686 was performed, followed by a 6 min resting-state magnetic resonance imaging (MRI) scan in ten patients with schizophrenia. To assess the relationship between striatal function and neurophysiological and behavioral functioning, salience processing was assessed using a mismatch negativity paradigm, an auditory event-related electroencephalographic measure, episodic memory was assessed using the Rey auditory verbal learning test (RAVLT) and executive functioning using trail-making test B. Reduced striatal PDE10A was associated with increased amplitude of low-frequency fluctuations (ALFF) within the putamen and substantia nigra, respectively. Higher ALFF in the substantia nigra, in turn, was associated with lower episodic memory performance. The findings are in line with a role for PDE10A in striatal functioning, and suggest that reduced striatal PDE10A may contribute to cognitive symptoms in schizophrenia.

Place, publisher, year, edition, pages
2020. Vol. 270, no 4, p. 451-459
Keywords [en]
Phosphodiesterase 10A, Schizophrenia, Striatum, Dopamine, Resting state
National Category
Psychiatry Neurosciences
Identifiers
URN: urn:nbn:se:uu:diva-392015DOI: 10.1007/s00406-019-01021-0ISI: 000531150600006PubMedID: 31119377OAI: oai:DiVA.org:uu-392015DiVA, id: diva2:1346485
Funder
Stiftelsen Söderström - Königska sjukhemmetThe Swedish Brain FoundationSwedish Research Council, 2016-02362Available from: 2019-08-28 Created: 2019-08-28 Last updated: 2021-05-12Bibliographically approved

Open Access in DiVA

fulltext(630 kB)344 downloads
File information
File name FULLTEXT01.pdfFile size 630 kBChecksum SHA-512
66d08ac383ebae6cf82f16a72d0be41485670886415ceaf07d37ea155858add2840efca450754df4a05109cff778b556079abf0c0c4c792a873c334ad0ef3088
Type fulltextMimetype application/pdf

Other links

Publisher's full textPubMed

Authority records

Persson, JonasSzalisznyo, KrisztinaAntoni, GunnarWall, AndersFällmar, DavidBodén, Robert

Search in DiVA

By author/editor
Persson, JonasSzalisznyo, KrisztinaAntoni, GunnarWall, AndersFällmar, DavidZora, HaticeBodén, Robert
By organisation
Ekselius: PsychiatryPreclinical PET-MRI PlatformPreparative Medicinal ChemistryRadiology
In the same journal
European Archives of Psychiatry and Clinical Neuroscience
PsychiatryNeurosciences

Search outside of DiVA

GoogleGoogle Scholar
Total: 344 downloads
The number of downloads is the sum of all downloads of full texts. It may include eg previous versions that are now no longer available

doi
pubmed
urn-nbn

Altmetric score

doi
pubmed
urn-nbn
Total: 721 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf